We have studied the extent to which mouse renal cytochrome P-450 isoenzymes are sexually differentiated, and the factor(s) regulating this dimorphism. Intriguingly, sex differences were not seen in the expression of a single cytochrome P-450 enzyme, but were observed in the expression of all P-450 isoenzymes detectable, encoded by six gene families or sub-families. This effect was mediated by testosterone, which had the capacity to both induce and repress P-450 gene expression, and which was independent of growth hormone. The changes in protein content were mirrored in all but one case by changes in the levels of mRNA, indicating that these genes contain hormone-responsive elements. These findings are consistent with numerous reports of sex differences in the susceptibility of the mouse kidney to the toxic and carcinogenic effects of drugs and environmental chemicals, many of which are metabolized to cytotoxic products by the cytochrome P-450-dependent mono-oxygenases. These data imply that circulating androgen levels will be an important factor in susceptibility of the kidney to toxic or carcinogenic compounds which require metabolic activation.
INTRODUCTION
The cytochrome P-450 mono-oxygenases are distributed widely in Nature and catalyse the insertion of an atom of molecular oxygen into the substrate. In mammals, these proteins constitute a supergene family, which, on the basis of sequence similarity and chromosomal location, has been divided into families and sub-families (Wolf, 1986; Nebert et al., 1989) . These enzymes are predominantly located in the liver, but are also present in all other tissues Guengerich, 1987) . Cytochrome P-450 enzymes will collectively metabolize a wide variety of drugs and foreign compounds, and as such play a vital role in host defence against chemical insult. Unfortunately, some reactions catalysed by these enzymes can result in activation of the compounds concerned, leading to chemical toxicity and cancer (Oesch, 1984) .
It is therefore important that the factor(s) which regulate cytochrome P-450 gene expression are elucidated. Previous work on the rat liver P-450 enzymes has demonstrated the role of growth hormone (GH) in determining hepatic P-450 levels (Mode et al., 1982 (Mode et al., , 1983 Blanck et al., 1986; Skett, 1987; Zaphiropoulos et al., 1989) . GH secretion is sexually differentiated in the rat (Eden, 1979) : in male rats, GH secretion is episodic, whereas in females, GH output is more continuous. This dimorphism is believed to be responsible for the distinct P-450 isoenzyme profiles seen in males and females; generally, hepatic xenobiotic metabolism is greater in male than in female rats. In mice, a similar situation exists, although the orientation of the effect is opposite, i.e. female hepatic xenobiotic metabolism is greater than that found in males (MacLeod & Shapiro, 1989) . Al- though direct measurement of GH profiles has yet to be carried out in mice, it has been possible to alter experimentally the GH secretion pattern, either by using transgenic mice or through naturally occurring GHdeficient strains (Norstedt & Palmiter, 1984) . These studies have demonstrated that modulation of GH secretion alters the expression of proteins and enzyme activities known to be sexually differentiated in the mouse liver.
For a number of reasons, the kidneys represent a particular target for the toxic effects of foreign compounds (Hook et al., 1979; Lock, 1987) . This tissue, on average, accounts for only 1 %0 of body weight, but receives 25 00 of the resting cardiac output. This, together with the inherently concentrative nature of the organ, results in extremely high concentrations of drugs and environmental chemicals in the proximal tubules (Hook et al., 1979) .
The profound sexual differentiation of the mouse kidney in terms of toxicological response is believed to be due to the sexual dimorphism of renal cytochrome P-450 enzymes. In order to investigate the degree of sexual differentiation of mouse renal cytochrome P-450 isoenzymes, and the potential role of GH in their regulation, the mouse strain 'little' was used . This strain, derived from C57BL/6, is deficient in the pituitary receptor for GH-releasing factor (Clark & Robinson, 1985; Jansson et al., 1986) , and as a consequence the homozygote (lit/lit) has only 5-10 / of normal circulating GH levels (Cheng et al., 1983) . The heterozygote (lit/ +) has been shown to possess the wildtype phenotype . No other biochemical or endocrinological abnormality has been described in this strain. For these reasons, the 'little'
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Vol. 266 675 mouse provides an ideal model for studying the role of GH in the regulation of P-450 gene expression, thus obviating the need for hypophysectomy as a means of removing the influence of GH.
In order to establish the extent of sexual differentiation of cytochrome P-450 enzymes in the mouse kidney, and the regulatory factor(s) involved, we have determined the levels of six distinct gene families or sub-families.
MATERIALS AND METHODS Chemicals
Unless otherwise indicated, all chemicals were purchased from either Sigma Chemical Co. Ltd., Poole, Dorset, U.K., or BDH Ltd., Glasgow, U.K., and were of analytical grade or better. Nitrocellulose was obtained from Schleicher and Schull, Dassell, Germany. Resorufin analogues were purchased from Molecular Probes Inc., Junction City, OR, U.S.A. Recombinant human GH (Genotropin) was a gift from Kabi-Vitrum (U.K.). Human GH has been shown previously to be physiologically active in C57BL/6 mice at the dosage used in these experiments (Norstedt & Palmiter, 1984 (Cattanach et al., 1977) . As a result, the ovaries and testes fail to develop postnatally.
After the last day of treatment, the animals were starved overnight before being killed by cervical dislocation. The organs were removed rapidly, rinsed in phosphate-buffered saline and frozen on solid CO2. Tissue was stored at -70°C until required.
Preparation of microsomes
Kidney microsomal samples were prepared by differential centrifugation from pooled tissue as described previously (Meehan et al., 1988) . Microsomes were finally resuspended in 10 mM-potassium phosphate buffer (pH 7.4)/I % (w/v) KCI/ 1 mM-EDTA/0.25M-sucrose, and stored at a concentration of 10-20 mg/ml at -40 'C.
Protein content was measured according to the method of Lowry et al. (1951) .
Cytochrome P-450 content was estimated by measuring the reduced carbon monoxide difference spectrum as described by Omura & Sato (1964) .
Metabolism of P450 substrates
The metabolism of the cytochrome P-450 substrates benzyloxyresorufin and coumarin were determined by measuring the rate of generation of the fluorescent products resorufin and 7-hydroxycoumarin respectively (Burke et al., 1985) . The metabolism of lauric acid was measured using "4C-labelled substrate and by subsequent separation of the products by t.l.c. (Orton & Parker, 1982) . This assay measures both 11-and 12-hydroxy lauric acid products.
Immunoblotting
SDS/PAGE was carried out according to the method of Laemmli (1970) , using 9 % separating gels.
Immunoblotting was performed essentially as described by Towbin et al. (1979) , with modifications according to Lewis et al. (1988) . After separation, proteins were transferred electrophoretically to nitrocellulose and probed with various antisera to rat liver cytochrome P-450s. Antibodies to the purified enzymes were isolated as described previously (Wolf et al., 1984 . These antibodies have been used previously in immunoblotting studies with mouse microsomal samples (Meehan et al., 1984) . In addition, the isoenzyme specificities of the antisera have been demonstrated by immunoblot analysis with expressed human recombinant P-450 proteins (results not shown). Cytochrome P-4501VA1 was isolated according to the method of Tamburini et al. (1984) , and was of high purity, running as a single band on SDS/ PAGE. Antibodies used were to P-4501A1, P-45011A1, P-45011B1, P-4501IC6, P-45011D1, P-45011E1, P-450111A1 and P-4501VA1. (For nomenclature system, see Nebert et al., 1989.) After revealing the immunoreactive polypeptides using horseradish peroxidase-labelled second antibody, the signal was enhanced with '25l-labelled Protein A (Amersham International) and subsequent autoradiography (Kodak X-Omat AR5 X-ray film) at -70 'C. Different exposure times were used in order to optimize the autoradiographic signal.
Northern blotting RNA was isolated from kidney samples of male and female mice as described previously by Cox (1968) . RNA concentration and purity were estimated spectrophotometrically, and RNA was tested for integrity and equivalence of loading by ethidium bromide staining of a denaturing formaldehyde gel. mRNA was separated and P-450 mRNA content was determined on denaturing formaldehyde gels using hybridization conditions described previously (Meehan et al., 1984) . Blots were washed at 65°C with 0.3 M-NaCI/0.03 M-trisodium citrate (pH 7.4). cDNA probes were labelled by the randompriming method (Rigby et al., 1977; Feinberg & Vogelstein, 1983 , 1984 .
Human cDNA probes used were P-4501A 1, P-4501IA3, P-45011B1, P-4501IC6, P-45011D1, P-45011E1 and P-450111A 1. The P-4501VA 1 cDNA probe was isolated from the rat (Earnshaw et al., 1988) . All probes were shown to be specific for their respective gene families in the mouse by their pattern of hybridization and by mapping in the recombinant inbred lines.
RESULTS
In our initial studies, we investigated the metabolism of certain model cytochrome P-450 substrates to see whether they were metabolized at different rates in male and female kidney samples (Fig. 1) . In agreement with previous findings on the metabolism of compounds such as chloroform (Eschenbrenner, 1945; Pohl et al., 1984) , a marked sex difference was observed. In female mice, total cytochrome P-450 levels were only 25 % of the male values, and the rates of metabolism of the substrates coumarin, benzyloxyresorufin and lauric acid were 11.5, 1.5 and 26% respectively of those measured in males.
These data clearly demonstrate the wide spectrum of P-450 activities which are sexually differentiated in the mouse. Interestingly, the three substrates used have been shown to be metabolized by P-450 forms from distinct gene families or sub-families, i.e. the P-45011A, P-45011B and P-4501V sub-families (Bains et al., 1985; Meehan et al., 1988; Miles et al., 1989) .
Western blot analysis, using antibodies to distinct P-450 families, was used to identify the proteins involved in such a sexual dimorphism (Fig. 2) Vol. 266
with the P-450-inducing agents phenobarbital and dexamethasone in order to induce the expression of P-450 forms which would otherwise be difficult to detect. The Western blots demonstrated that P-450s from almost all the known gene families involved in foreign compound metabolism are expressed in the kidney, and up to eleven cytochrome P-450 isoenzymes from six gene families or sub-families were sexually differentiated in a striking manner. In certain cases, several members of a gene family exhibited differences. In the P-45011A subfamily, an isoenzyme is expressed only in females, but the level of expression of the lower-molecular-mass form is greater in males. Interestingly, a different antibody preparation, raised to a mouse protein of the P-45011A sub-family, gave the same banding pattern but in addition recognized a second male-specific band of intermediate molecular mass (results not shown). Polyclonal antibodies to rat P-450IIA1 will inhibit completely coumarin hydroxylase activity in both mouse and human liver microsomes (results not shown). Thus it may be assumed that this P-450 isoenzyme alone carries out the 7-hydroxylation of coumarin, and that the differences in P-45011A protein levels (Fig. 2) will explain the observed dimorphism in coumarin hydroxylase activity (Fig. 1) . Similarly, the association of lauric acid hydroxylase .I. Fig. 3 . Cytochrome P450 mRNA analysis of male and female mouse kidney samples RNA was isolated and Northern blotting carried out as described in the Materials and methods section. The following cDNA probes were used :P-450IIA3, P-4501IB1, P-4501IC6, P-45011E1 and P-4501VA 1. Con, control; Dex, dexamethasone-treated male and female (+ / +) C57BL/6 mice.
lies, Alpha, Mu and Pi (Hayes et al., 1983; Stockman et al., 1987) . No evidence for sexual differentiation of the GST families in the kidney was seen (Fig. 2) . A similar result was obtained for the microsomal GST (results not shown). P-450 reductase levels were equivocal (Fig. 2) , suggesting a slight sexual dimorphism, although this was much less dramatic than that demonstrated by the P-450 isoenzymes.
Northern blot analysis was carried out to determine whether the changes in protein levels were mirrored by changes in the mRNA content (Fig. 3) . In almost all cases, a higher level of mRNA was measured in males than in females, in agreement with the higher protein levels seen on Western blots. These data confirm the sexual differentiation of P-450s from the gene families studied, and also indicate that regulation may be at the transcriptional level. One anomaly was the finding of no sex difference in mRNA levels using the P-4501VA I cDNA probe. The reason for this is unclear, but may indicate some other form of regulation. Samples were also probed with P-450IA1, P-45011D and P-450111AI cDNAs, but no hybridization to these probes could be detected (results not shown).
The profile of P-450 isoenzymes in the GH-deficient 'little' mice (lit/lit) was identical with that found in the heterozygous (lit/+) or normal (+/+) strains, indicating that GH is not involved in the sexual differentiation of P-450 expression in the kidney (Fig. 2) . This was further substantiated by treating female lit/lit mice with GH in a male pattern; the renal P-450 isoenzyme profile remained that of a female (Fig. 4) . These data are in activity with P-4501VA 1 is well documented (Bains et al., 1985) . Two P-4501V-related proteins were expressed at much higher levels in males, thus explaining the higher rate of lauric acid metabolism in this sex. These proteins correspond to the two P-4501VA transcripts observed on Northern blots (Fig. 3) . In four other mouse species, C3H, DBA, C57L and AKR, sexual differentiation of kidney microsomal lauric acid metabolism was also evident (results not shown). The metabolism of benzyloxyresorufin is associated with proteins of the P-45011B gene family (Meehan et al., 1988) , and a protein within this family, which is expressed at higher levels in males and is strongly induced by dexamethasone but not phenobarbital, is essentially absent from female samples. Both male-and female-specific bands were recognized by antibodies to the P-45011C gene family; also, dexamethasone appeared to induce in male mice, and suppress in females, the expression of a high-molecular-mass protein. A single protein associated with the P-450IIE family was detected in male, but not in female, samples. Although members of the P-450111 family were expressed at very low levels, it appears that two, possibly three, members of this gene family are expressed in males, but not in females. Interestingly, proteins of this gene family did not appear to be induced by dexamethasone in the kidney, which is contrary to the regulation of these proteins in the liver. P-450 from the P-450IlD family could not be detected in the mouse kidney (results not shown).
In order to establish whether other drug-metabolizing enzymes are also sexually differentiated in the mouse kidney, Western blots were carried out using antibodies to cytochrome P-450 reductase, and to the cytosolic glutathione S-transferases (GST) from three gene fami- by testosterone (a) Microsomal protein (30 ,ug) and P-450 standards (0.4 pmol) were separated by SDS/PAGE, immunoblotted and probed with polyclonal antisera raised to rat liver cytochrome P-450 isoenzymes. The standards (std) used were P-45011Al, P-45011BI, P-4501IC6, P-450111AI and P-4501VAI, isolated from rat liver. No P-450IIE standard was available. C, control animals receiving corn oil vehicle only; 2T and 4T, animals receiving a daily dose of testosterone propionate of 2 and 4 mg/kg body weight respectively, as described in the Materials and methods section. (b) Kidney microsomal benzyloxyresorufinmetabolizing activity in sham-operated and castrated male and intact female mice. 1, Control; IE, 2 mg of testosterone/kg; U, 4 mg of testosterone/kg. Details are given in the Materials and methods section.
contrast with the situation in the liver, where an altered expression of hepatic P-450 isoenzymes in the P-45011B and P-45011C gene families is observed in 'little' mice (results not shown).
As GH did not appear to mediate the differences observed, and in view of the known effects of testosterone on the toxicological response of the kidney, we investigated whether steroid hormones might be involved. Striking effects of castration and testosterone treatment were observed (Figs. 4 and 5) . Castration of male mice converted their pattern of cytochrome P-450 expression Vol. 266 to that seen in females, the male pattern being restored by treatment with testosterone (Fig. 5a) . Treatment of female mice with testosterone resulted in suppression of the female P-450 profile and induction of the male pattern. These findings explain reports that testosterone sensitizes female mice to the nephrotoxic effects of compounds such as chloroform, and are consistent with previous reports that proteins from the P-45011A and P-45011E sub-families are regulated in the kidney by testosterone (Squires & Negishi, 1988; Hong et al., 1989) . Benzyloxyresorufin metabolism by kidney microsomes (Fig. 5b ) from these mice reflected the results obtained from Western blotting with anti-P-45011B antiserum. Castration of males suppressed the metabolism to female (undetectable) levels, whereas testosterone treatment of intact females or castrated males induced the metabolism from undetectable to male levels. Interestingly, the induction of P-4501IB by testosterone was extremely marked, in terms of both immunoreactivity on a Western blot (Fig. 5a ) and of activity with benzyloxyresorufin ( Fig. Sb) , and appeared to be dose-dependent.
Treatment of female lit/lit mice with testosterone resulted in a male P-450 isoenzyme profile (Fig. 4) . This suggests that testosterone is not operating via the pituitary and modulation of the pattern of GH levels. This is substantiated by the finding that the imposition of a male GH pattern on female lit/lit mice had no effect on the renal P-450 isoenzyme profile (Fig. 4) . Western blotting of kidney microsomes from male and female hpg mice did not reveal sexual dimorphism in the renal P-450 isoenzyme profile, both males and females exhibiting the same ('female') pattern of P-450 expression (results not shown). Ovariectomy of female mice had no effect on the pattern of renal P-450 isoenzyme expression (results not shown); thus oestrogens are not involved in determining the female P-450 levels. The expression of cytochrome P-450 genes is therefore inducible or repressible by testosterone, acting either directly or indirectly.
DISCUSSION
There are numerous reports describing sex differences in susceptibility to environmental toxins and carcinogens, in animal models as well as in man. These differences are observed in a variety of tissues, but are perhaps best exemplified by studies in the liver and the kidney. In the latter case, it is remarkable that a host of compounds exhibit profound sex differences in their effects. For example, chloroform, which is activated to its nephro--toxic form, phosgene, by the cytochrome P-450 monooxygenase system, is highly toxic to the male mouse kidney, but is essentially non-toxic in females (Eschenbrenner, 1945; Pohl et al., 1984) . Other studies have demonstrated a greater incidence of renal neoplasms in male mice with a variety of compounds, including 2,4-dinitrotoluene, tris-(2,3-dibromopropyl) phosphate, 4,4'-dichlorophenyltrichloroethane, basic lead acetate and ethylnitrosourea (Van Esch & Kroes, 1969; Tomatis et al., 1972; Vesselinovitch et al., 1973; Reznik et al., 1979; Hong et al., 1980 -----------kidney, sexual dimorphism in the rate of activation of nephrotoxins by cytochrome P-450s has been proposed as a mechanism for some of the toxicological differences observed (Hook et al., 1979; Rush et al., 1984; Lock, 1987) . The implication from these studies is that cytochrome P-450s are regulated in the kidney in a sexspecific manner (Hawke & Welch, 1985) . This possibility, however, is difficult to reconcile with the remarkably broad range of compounds exhibiting sexual differentiation, unless several cytochrome P-450 forms are sexually differentiated. The results presented in this paper demonstrate that P-450 genes from all gene families detectable in the kidney are subject to hormonal regulation, either directly or indirectly.
Immunoblots indicated that there may be eleven or more sexually differentiated P-450 forms expressed in the mouse kidney. The actual number of forms should, however, be interpreted with some caution, as antibodies to rat liver P-450 isoenzymes were used. There is therefore the possibility that the antibodies may cro s-react with other gene families in the mouse. However/several lines of evidence indicate that this is not the case. The antibodies used have been shown to be specific inhibitors of mono-oxygenase reactions catalysed by specific P-450 forms in the mouse, and have been shown to distinguish between gene families based on the mode of regulation of the proteins which they recognize (Meehan et al., 1988 ; R. R. Meehan & C. R. Wolf, unpublished work). In addition, the antibodies have also been shown to exhibit specificity towards recombinant human P-450 forms (L. Forrester, F. Gonzalez & C. R. Wolf, unpublished work) .
A number of cellular enzymes have been reported to be present at higher levels in the male mouse kidney than in the female, and sexual dimorphism in subcellular organelles has also been reported (Koenig et al., 1980) . The molecular basis for these sex differences in many cases has not been studied in detail, although steroid hormones have been implicated (Koths et al., 1972; Smith et al., 1984) . Studies of certain androgen-regulated genes (non-P-450) in the mouse kidney and other murine tissues have shown that the presence of the androgen receptor is required for testosterone to have its regulatory effect (Felder et al., 1988) , and that testosterone stimulates transcription (Watson & Paigen, 1988) . There are preliminary reports describing areas of sequence similarity in the 5' non-coding region of androgen-regulated genes from various rat and mouse tissues (Kandala et al., 1985; Williams et al., 1985) , implying the presence of androgenresponsive elements. In the case of P-450s, it will be useful to establish whether testosterone is acting at the transcriptional level by stimulating P-450 mRNA synthesis. If this proves to be the case, then the presence of hormone-responsive elements in a large number of mouse P-450 genes from several gene families may be implied.
Hormonal regulation of P-450 genes in the kidney could well explain the increasing number of reports demonstrating sex differences in susceptibility to toxins and carcinogens. In humans, for example, Balkan Endemic Nephropathy, which has been associated with exposure to the fungal toxin ochratoxin A, believed to be a P-450 substrate, exhibits a sexual dimorphism in its incidence (Castegrano et al., 1987) . There is also a profound difference in the nephrotoxicity and carcinogenicity of this toxin in mice, which appears to be related to its rate of metabolic activation (Bendele et al., 1985) .
Moreover, steroid hormones have been implicated in the aetiology of renal cancer, which occurs twice as frequently in men than in women (Bloom, 1971 (Bloom, , 1973 . This could relate to differences in cytochrome P-450 levels.
